[Non-hormonal treatment of postmenopausal osteoporosis]. 1987

D Briançon, and P J Meunier
Hôpital Reine Hortense, Aix-les-Bains.

Non hormonal treatments for postmenopausal osteoporosis are curative and preventive treatments that do not call for sex hormones. Curative treatments aim to reduce the frequency of relapsing vertebral fractures and they mainly consist in sodium fluoride (50 mg/day) combined with Calcium (1 g element/day). Preventive treatments are intended to prevent the occurrence of vertebral fractures. They consist in calcium, physical exercise, vitamin D and calcitonin. Calcium and physical exercise are simple and inexpensive means which may be convenient for every woman, with no need for any preselection, and which can be combined together very well. They are however less effective than estrogen--progestogen combination. Vitamin D and its metabolites do not seem to be helpful for prevention of postmenopausal osteoporosis. Calcitonin is likely to offer good prospects for the future, because it has no major side effect and is able to restrain bone loss. Its use however will be dependent on a change in its mode of administration (intranasal), and a lowering of its cost (bacterial synthesis?). Lastly, a great effort has to be directed towards a thorough knowledge of osteoporosis risk factors, in order to carry out their elimination and the screening of high risk female patients.

UI MeSH Term Description Entries
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

D Briançon, and P J Meunier
January 2008, Gynecologie, obstetrique & fertilite,
D Briançon, and P J Meunier
October 2007, Climacteric : the journal of the International Menopause Society,
D Briançon, and P J Meunier
May 1983, British medical journal (Clinical research ed.),
D Briançon, and P J Meunier
June 1983, British medical journal (Clinical research ed.),
D Briançon, and P J Meunier
July 1983, British medical journal (Clinical research ed.),
D Briançon, and P J Meunier
March 1983, British medical journal (Clinical research ed.),
D Briançon, and P J Meunier
August 1983, British medical journal (Clinical research ed.),
D Briançon, and P J Meunier
June 1990, Revue medicale de la Suisse romande,
D Briançon, and P J Meunier
September 1999, Orvosi hetilap,
D Briançon, and P J Meunier
January 1997, Revista do Hospital das Clinicas,
Copied contents to your clipboard!